SEC Comment Letter 0000000000-24-006923 to BiomX Inc. (PHGE)

BiomX Inc.
Date: June 17, 2024 · CIK: 0001739174 · Accession: 0000000000-24-006923

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38762

Date

June 17, 2024

Author

Jonathan Solomon

Form

UPLOAD

Company

BiomX Inc.

Letter

United States securities and exchange commission logo June 17, 2024 Jonathan Solomon Chief Executive Officer BiomX Inc. 22 Einstein St., 4th Floor Ness Ziona, Israel 7414003 Re:BiomX Inc. Preliminary Proxy Statement on Schedule 14A Filed May 28, 2024 File No. 001-38762 Dear Jonathan Solomon: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Alla Digilova, Esq.

Show Raw Text

United States securities and exchange commission logo
June 17, 2024
Jonathan Solomon
Chief Executive Officer
BiomX Inc.
22 Einstein St., 4th Floor
Ness Ziona, Israel 7414003
Re:BiomX Inc.
Preliminary Proxy Statement on Schedule 14A
Filed May 28, 2024
File No. 001-38762
Dear Jonathan Solomon:
            We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Alla Digilova, Esq.

SecProbe.io